SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 27 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $211,000 | +50.7% | 57,000 | 0.0% | 0.00% | – |
| Q4 2014 | $140,000 | -26.7% | 57,000 | 0.0% | 0.00% | – |
| Q3 2014 | $191,000 | +25.7% | 57,000 | 0.0% | 0.00% | – |
| Q2 2014 | $152,000 | +19.7% | 57,000 | 0.0% | 0.00% | – |
| Q1 2014 | $127,000 | +17.6% | 57,000 | +3.6% | 0.00% | – |
| Q4 2013 | $108,000 | +28.6% | 55,000 | 0.0% | 0.00% | – |
| Q3 2013 | $84,000 | – | 55,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 219,440,000 | $585,836,000 | 7.18% |
| SYMPHONY ASSET MANAGEMENT LLC | 11,727,000 | $31,333,000 | 3.26% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 28,200,000 | $75,347,000 | 0.92% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,943,000 | $31,896,000 | 0.70% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $1,606,000 | 0.62% |
| BNP PARIBAS FINANCIAL MARKETS | 1,200,000 | $320,628,000,000 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 3,000,000 | $7,998,000 | 0.10% |
| Visium Asset Management, LP | 2,000,000 | $5,335,000 | 0.08% |
| SG Americas Securities, LLC | 22,800 | $6,103,000 | 0.04% |
| LORD, ABBETT & CO. LLC | 10,988,000 | $29,414,000 | 0.03% |